Who
Darrin Uecker
Chief Technology Officer
Company insider
Files Form 4 as: Chief Technology Officer, Pulse Biosciences; VP, R&D and Operations, Conceptus; Chief Technology Officer, Rita Medical Systems.
In numbers
- Trades disclosed
- 46
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $2.3M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 8 Mar 2006
- Last trade
- 23 Mar 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Mar 2026filed 3 Apr 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 23 Mar 2026filed 3 Apr 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —61,534 at $0.00 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $80K20,000 at $4.00 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $324K20,000 at $16.21 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $246K61,534 at $4.00 | filing |
| 17 Sep 2025filed 18 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $400K100,000 at $4.00 | filing |
| 16 Sep 2025filed 18 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 16 Sep 2025filed 18 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $100K25,000 at $4.00 | filing |
| 16 Sep 2025filed 18 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $407K25,000 at $16.28 | filing |
| 15 Sep 2025filed 15 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 15 Sep 2025filed 15 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $100K25,000 at $4.00 | filing |
| 15 Sep 2025filed 15 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $394K25,000 at $15.77 | filing |
| 12 Sep 2025filed 15 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 12 Sep 2025filed 15 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $100K25,000 at $4.00 | filing |
| 12 Sep 2025filed 15 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Sold | $358K25,000 at $14.32 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PLSE Pulse BiosciencesMedical Devices | SEC FORM 4 Code M | $100K25,000 at $4.00 | filing |
News
Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule TreatmentPLSE · rttnews.com · 14 Oct 2026
0 headlines in the last 90 days name Darrin Uecker; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.